Author: United States. President's Cancer Panel. National Committee to Review Current Procedurs for Approval of New Drugs for Cancer and AIDS.Publisher:
ISBN:
Category : Antimitotic agents
Languages : en
Pages : 66
Book Description
Final Report of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS.
Author: United States. President's Cancer Panel. National Committee to Review Current Procedurs for Approval of New Drugs for Cancer and AIDS.Publisher:
ISBN:
Category : Antimitotic agents
Languages : en
Pages : 66
Book Description
National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS
Author: United States. President's Cancer PanelPublisher:
ISBN:
Category :
Languages : en
Pages : 200
Book Description
The Changing Economics of Medical Technology
Author: Institute of MedicinePublisher: National Academies Press
ISBN: 030904491X
Category : Medical
Languages : en
Pages : 225
Book Description
Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.
Food and Drug Administration Advisory Committees
Author: Institute of MedicinePublisher: National Academies Press
ISBN: 0309048370
Category : Medical
Languages : en
Pages : 239
Book Description
Like many other agencies of the federal government, the Food and Drug Administration (FDA) relies extensively on external advisory committees for independent scientific and technical advice. Recognizing that the existing advisory committee system is essentially sound, this volume recommends ways of enhancing the use of these committees in the evaluation of drugs, biological materials, and medical devices; strengthening the agency's management of the system; and increasing the accountability of the system to the public. In doing so, it examines and makes recommendations on such issues as the recruitment of committee members, the FDA's management of financial conflict of interest and intellectual bias among members, and the operations and management of the advisory committee system.
Commission on the Federal Drug Approval Process
Author: United States. Commission on the Federal Drug Approval ProcessPublisher:
ISBN:
Category : Drug approval
Languages : en
Pages : 124
Book Description
AIDS Bibliography
Author: Regulation of Dietary Supplements
Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the EnvironmentPublisher:
ISBN:
Category : Health & Fitness
Languages : en
Pages : 640
Book Description
Pharmaceutical R&D costs, risks, and rewards.
Author: Publisher: DIANE Publishing
ISBN: 1428921036
Category :
Languages : en
Pages : 360
Book Description
FDA Reform Legislation
Author: United States. Congress. House. Committee on Commerce. Subcommittee on Health and the EnvironmentPublisher:
ISBN:
Category : Law
Languages : en
Pages : 466
Book Description
The Handbook of Psychopharmacology Trials
Author: Marc HertzmanPublisher: NYU Press
ISBN: 9780814735329
Category : Psychology
Languages : en
Pages : 492
Book Description
Each year pharmaceutical companies invest billions of dollars in clinical trials of drugs used for the treatment of central nervous system diseases. Due to enormous progress in basic pharmaceutical research in recent years, controlled tests of new medications are flourishing and these trials have rapidly become an intense focus of practical medical research. Aware of the complexities presented in the design, execution, and evaluation of clinical trials, Marc Hertzman and Douglas E. Feltner bring together a collection of essays that dissect the scientific, psychosocial, political, and ethical concerns that must be examined for any CNS trial. The internationally known contributors examine concerns about ethics and cost; the FDA and its regulatory impact; and the implementation of a variety of trials, for disorders such as schizophrenia, alcoholism, eating disorders, insomnia, and aggression. The editors carefully consider important social issues including the considerations related to women's special needs; and the relative merits of psychotherapy and medications. The Handbook of Psychopharmocology Trials provides an up-to- date and stimulating exploration of important issues on the subject of CNS Clinical trials.